Umbilical cord blood: An evolving stem cell source for sickle cell disease transplants

Stem Cells Translational Medicine

Volumn 2, Issue 5, 2013, Pages 337-340

  Shenoy, Shalini ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD45 ANTIGEN; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY; TREOSULFAN;

ARTICLE; AUTOIMMUNITY; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KIDNEY DISEASE; LIVER DYSFUNCTION; LIVER VENOOCCLUSIVE DISEASE; MORTALITY; PAIN; PULMONARY HYPERTENSION; SEIZURE; SICKLE CELL ANEMIA; STEM CELL EXPANSION; UMBILICAL CORD BLOOD; VASCULAR DISEASE; WISKOTT ALDRICH SYNDROME;

EID: 84877668735     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0180     Document Type: Article

References (39)

1. Scothorn D, Price C, Schwartz D. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002;140:348-354.
2. Walters M, Hardy K, Edwards S et al. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant 2010;16:263-272.
3. Eggleston B, Patience M, Edwards S et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anemia: Results of the multicenter study of haematopoietic cell transplantation for sickle cell anemia. Br J Haematol 2007;136:673-676.
4. Fitzhugh C, Lauder N, Jonassaint J et al. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 2010;85:36-40.
5. Roth M, Krystal J, Manwani D et al. Stem cell transplant for children with sickle cell anemia: Parent and patient interest. Biol Blood Marrow Transplant 2012;18:1709-1715.
6. Shenoy S. Has stem cell transplantation come of age in the treatment of sickle cell disease? Bone Marrow Transplant 2007;40:813-821.
7. Freed J, Talano J, Small T et al. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'Whom, when and how.' Bone Marrow Transplant 2012;47:1489-1498.
8. Mentzer W, Heller S, Pearle P et al. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 1994;16:27-29.
9. Walters M, Patience M, Leisenring W et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001;7: 665-673.
10. Eapen M, Rubinstein P, Zhang M et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: A comparison study. Lancet 2007;369:1947-1954.
11. Barker J, Scaradavou A, Stevens C. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010;115:1843-1849.
12. Kamani N, Spellman S, Hurley CK et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant 2008;14:1-6.
13. Page K, Zhang L, Mendizabal A et al. Total colony-forming units are a strong independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: A single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant 2011;17:1362-1374.
14. Rocha V, Spellman S, Zhang M et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012;18:1890-1896.
15. Norkin M, Lazarus H, Wingard J. Umbilical cord blood graft enhancement strategies: Has the time come to move these into the clinic? Bone Marrow Transplant 2012 (in press).
16. Delaney C, Ratajczak M, Laughlin M. cord blood stem cell engraftment in adult patients. Expert Rev Hematol 2010;3:273-283.
17. de Lima M, McNiece I, Robinson S et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 2012;367: 2305-2315.
18. Lee S, Kamani N, Confer D. Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts. Biol Blood Marrow Transplant 2008;14(suppl 1):112-119.
19. Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-2143.
20. Hsieh M, Kang E, Fitzhugh C et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361: 2309-2317.
21. Hsieh M, Wu C, Tisdale J. In mixed hematopoietic chimerism, the donor red cells win. Haematologica 2011;96:13-15.
22. Lisini D, Zecca M, Giorgiani G et al. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica 2008;93:1859-1867.
23. Moratto D, Giliani S, Bonfim C et al. Longterm outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: An international collaborative study. Blood 2011;118:1675-1684.
24. Ruggeri A, Eapen M, Scaravadou A et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011;17:1375-1382.
25. Adamkiewicz T, Szabolcs P, Haight A et al. Unrelated cord blood transplantation in children with sickle cell disease: Review of fourcenter experience. Pediatr Transplant 2007; 11:641-644.
26. Jaing T, Hung I, Yang C et al. Unrelated cord blood transplantation for thalassaemia: A single-institution experience of 35 patients. Bone Marrow Transplant 2012;47:33-39.
27. Walters M, Sullivan K, Bernaudin F et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995;85:879-884.
28. Khalil A, Zaidman I, Elhasid R et al. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy. Pediatr Hematol Oncol 2012;29:694-703.
29. Horan J, Liesveld J, Fenton P et al. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant 2005;35: 171-177.
30. Iannone R, Casella J, Fuchs E et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003;9:519-528.
31. Jacobsohn D, Duerst R, Tse M et al. Reduced intensity hematopoietic stem-cell transplantation for the treatment of non-malignant diseases in children. Lancet 2004;364:156-162.
32. Mazur M, Kurtzberg J, Halperin E et al. Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J Pediatr Hematol Oncol 2006;28:840-844.
33. Krishnamurti L, Blazar B, Wagner J. Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med 2001; 344:68.
34. Kamani N, Walters M, Carter S et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: Results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant 2012;18:1265-1272.
35. Shenoy S, Grossman W, DiPersio J et al. A novel reduced-intensity stem cell transplant regimen for non-malignant disorders. Bone Marrow Transplant 2005;35:345-352.
36. Bednarski J, Le C, Murray L et al. Immune reconstitution following reduced intensity stem cell transplantation for non-malignant disorders in children: Poster presentation at Tandem Meeting 2013. Biol Blood Marrow Transplant 2013;19:S200.
37. Schmidt-Hieber M, Schwarck S, Stroux A et al. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: The important impact of in vivo T cell depletion. Int J Hematol 2010;91:877-885.
38. Bernardo M, Piras E, Vacca A et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 2012;120:473-476.
39. Sauter C, Abboud M, Jia X et al. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biol Blood Marrow Transplant 2011;17:1460-1471.